Page last updated: 2024-11-10

cloprednol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cloprednol: relative anti-inflammatory potency twice prednisolone; synthetic glucocorticoid; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5284535
CHEMBL ID1697832
CHEBI ID135619
SCHEMBL ID4886
MeSH IDM0058256

Synonyms (35)

Synonym
cloradryn
syntestan
novacort
cloprednol
rs-4691
(11beta)-6-chloro-11,17,21-trihydroxypregna-1,4,6-triene-3,20-dione
cloradryn (tn)
5251-34-3
cloprednol (usan/inn)
D03561
CHEBI:135619
CHEMBL1697832
(8s,9s,10r,11s,13s,14s,17r)-6-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8h-cyclopenta[a]phenanthren-3-one
unii-syp56o3gjg
6-chloro-11beta,17,21-trihydroxypregna-1,4,6-triene-3,20-dione
einecs 226-052-6
cloprednolum
pregna-1,4,6-triene-3,20-dione, 6-chloro-11,17,21-trihydroxy-, (11beta)-
syp56o3gjg ,
cloprednolum [inn-latin]
rs 4691
6-chloro-11beta,17alpha, 21-trihydroxypregn-1,4,6-triene-3,20-dione
cloprednol [usan:inn:ban]
pregna-1,4,6-triene-3,20-dione, 6-chloro-11,17,21-trihydroxy-, (11.beta.)-
cloprednol [mi]
cloprednol [inn]
cloprednol [who-dd]
cloprednol [mart.]
cloprednol [usan]
SCHEMBL4886
DTXSID1022849
Q3680915
DB13843
(8s,9s,10r,11s,13s,14s,17r)-6-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-3h-cyclopenta[a]phenanthren-3-one
AKOS040746714

Research Excerpts

Overview

Cloprednol is an oral synthetic glucocorticoid with a short serum half-life of 110 minutes. It is under investigation for use in asthma.

ExcerptReferenceRelevance
"Cloprednol is a new oral corticosteroid with a short half-life that is presently under investigation for use in asthma. "( Cloprednol therapy in steroid-dependent asthma.
Bierman, CW; Dorsett, CS; Kelley, VC; Pierson, WE; Shapiro, GG; Tattoni, DS, 1979
)
3.15
"Cloprednol is an oral synthetic glucocorticoid with a short serum half-life of 110 minutes. "( Long-term cloprednol use in chronic asthma.
Gavani, UD; Hyde, JS; Khurana, S; Manaligod, LM, 1979
)
2.1

Bioavailability

ExcerptReferenceRelevance
"The bioavailability of cloprednol, a new systemic corticosteroid, was examined in a 12-subject crossover study in which two capsules, a tablet, and a solution were tested."( Cloprednol bioavailability in humans.
Fratis, A; Mroszczak, EJ; Runkel, R; Segre, E; Strand, LJ; Tomlinson, RV, 1978
)
2.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
21-hydroxy steroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (76.92)18.7374
1990's2 (15.38)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.84 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.06 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (13.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (13.33%)4.05%
Observational0 (0.00%)0.25%
Other11 (73.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]